Skip to main content

Scientists Discover Way to Send Information into Black Holes Without Using Energy

3 comments

A Common Blood Pressure Pill Could Help Defeat Deadly Superbugs

Antibiotic resistance is one of the biggest health challenges of our time. Each year, millions of people suffer from infections that no longer respond to standard treatments. Among the most dangerous of these “superbugs” is Methicillin-resistant Staphylococcus aureus, commonly known as MRSA—a bacterium that can survive even the strongest antibiotics.

Now, a new study published in Nature Communications offers a surprising and hopeful breakthrough. Researchers have discovered that a widely used blood pressure medication, Candesartan cilexetil, may be effective in fighting these stubborn infections.

The Growing Threat of Antibiotic Resistance

Antibiotics have been the backbone of modern medicine for decades. They help treat infections, make surgeries safer, and save millions of lives every year. However, over time, bacteria have evolved to resist these drugs. This process is known as antibiotic resistance.

Infections caused by resistant bacteria are harder to treat, often requiring stronger medications, longer hospital stays, and sometimes leading to death. MRSA is one of the most well-known examples. It can cause skin infections, pneumonia, and even life-threatening bloodstream infections. What makes MRSA especially dangerous is its ability to survive despite treatment with commonly used antibiotics.

A New Approach: Reusing Existing Drugs

Developing new antibiotics is expensive and time-consuming. It can take years—sometimes decades—before a new drug reaches patients. Because of this, scientists are exploring a smarter and faster strategy: repurposing existing medications.

This means taking drugs that are already approved for one condition and testing whether they can treat another. Since these drugs have already been proven safe for human use, the process of bringing them into new treatments can be much quicker.

That’s exactly what researchers led by Eleftherios Mylonakis set out to do. Instead of creating a new antibiotic from scratch, they investigated whether existing drugs could weaken bacteria in new ways.

How a Blood Pressure Drug Fights Bacteria

The research team focused on how drugs might affect the physical structure of bacteria, especially their cell membranes. The cell membrane is like a protective barrier that keeps the bacteria alive. If this barrier is damaged, the bacteria cannot function properly and eventually die.

In laboratory experiments, the team found that Candesartan cilexetil can disrupt the membrane of MRSA bacteria. This disruption weakens the bacteria, making it harder for them to survive.

The study’s first author, Nagendran Tharmalingam, and his colleagues demonstrated several important effects:

  • The drug killed MRSA bacteria at different stages of growth

  • It interfered with essential cell functions

  • It reduced the formation of biofilms

Why Biofilms Matter

Biofilms are clusters of bacteria that stick together and form a protective layer. This layer makes the bacteria much harder to kill because it blocks antibiotics from reaching them effectively.

MRSA often forms biofilms on medical devices, wounds, and tissues, making infections persistent and difficult to treat. By reducing biofilm formation, the drug helps expose the bacteria, making them more vulnerable to treatment.

Boosting the Power of Existing Antibiotics

One of the most exciting findings from the study is that the blood pressure drug doesn’t just work alone—it also enhances the effectiveness of existing antibiotics.

Researchers found that Candesartan cilexetil can improve the performance of antibiotics like Gentamicin and Polymyxin B.

This combination approach could be a game-changer. Instead of replacing antibiotics, the drug makes them work better. It essentially weakens the bacteria’s defenses, allowing antibiotics to do their job more effectively.

Why This Discovery Is Important

This breakthrough offers several major advantages:

1. Faster Treatment Development

Since the drug is already approved for blood pressure, it has a known safety profile. This could speed up the process of testing and approval for its new use.

2. Cost-Effective Solution

Developing new antibiotics is extremely expensive. Repurposing existing drugs is much more affordable, making treatments more accessible.

3. A New Strategy Against Superbugs

Instead of directly attacking bacteria in the traditional way, this approach weakens their structure. This reduces the chances of resistance developing quickly.

What Comes Next?

While the results are promising, it’s important to understand that this research is still in its early stages. The experiments were conducted in laboratory settings, not in human patients.

Before this treatment can be widely used, further studies and clinical trials are needed to confirm:

  • Its effectiveness in real-world infections

  • The correct dosage for treating bacterial infections

  • Any potential side effects when used for this purpose

If these trials are successful, the drug could become part of a new class of treatments designed to fight antibiotic-resistant bacteria.

A Glimpse Into the Future of Medicine

This discovery reflects a larger shift in how scientists are tackling global health challenges. Instead of relying only on new drug development, researchers are thinking creatively—finding new uses for existing tools.

The idea of repurposing medications could open the door to many more breakthroughs. Drugs originally designed for one condition might help treat completely different diseases, saving time, money, and lives.

Conclusion

The fight against antibiotic-resistant bacteria is far from over, but discoveries like this offer real hope. A simple, widely available blood pressure drug may soon play a role in defeating one of the most dangerous superbugs.

By weakening bacteria, reducing biofilms, and boosting antibiotic effectiveness, Candesartan cilexetil could become a powerful new tool in modern medicine.

As research continues, this unexpected solution reminds us of an important truth: sometimes, the answers to our biggest problems are already within reach—we just need to look at them in a new way.

Reference: Nagendran Tharmalingam et al, Candesartan cilexetil disrupts methicillin-resistant Staphylococcus aureus membrane and potentiates gentamicin and polymyxin B activity, Nature Communications (2026). DOI: 10.1038/s41467-026-70173-0

Comments

Post a Comment

Popular

Scientists Discover Way to Send Information into Black Holes Without Using Energy

For years, scientists believed that adding even one qubit (a unit of quantum information) to a black hole needed energy. This was based on the idea that a black hole’s entropy must increase with more information, which means it must gain energy. But a new study by Jonah Kudler-Flam and Geoff Penington changes that thinking. They found that quantum information can be teleported into a black hole without adding energy or increasing entropy . This works through a process called black hole decoherence , where “soft” radiation — very low-energy signals — carry information into the black hole. In their method, the qubit enters the black hole while a new pair of entangled particles (like Hawking radiation) is created. This keeps the total information balanced, so there's no violation of the laws of physics. The energy cost only shows up when information is erased from the outside — these are called zerobits . According to Landauer’s principle, erasing information always needs energy. But ...
3 comments
Read more

Black Holes That Never Dies

Black holes are powerful objects in space with gravity so strong that nothing can escape them. In the 1970s, Stephen Hawking showed that black holes can slowly lose energy by giving off tiny particles. This process is called Hawking radiation . Over time, the black hole gets smaller and hotter, and in the end, it disappears completely. But new research by Menezes and his team shows something different. Using a theory called Loop Quantum Gravity (LQG) , they studied black holes with quantum corrections. In their model, the black hole does not vanish completely. Instead, it stops shrinking when it reaches a very small size. This leftover is called a black hole remnant . They also studied something called grey-body factors , which affect how much energy escapes from a black hole. Their findings show that the black hole cools down and stops losing mass once it reaches a minimum mass . This new model removes the idea of a “singularity” at the center of the black hole and gives us a better ...
Post a Comment
Read more

How Planetary Movements Might Explain Sunspot Cycles and Solar Phenomena

Sunspots, dark patches on the Sun's surface, follow a cycle of increasing and decreasing activity every 11 years. For years, scientists have relied on the dynamo model to explain this cycle. According to this model, the Sun's magnetic field is generated by the movement of plasma and the Sun's rotation. However, this model does not fully explain why the sunspot cycle is sometimes unpredictable. Lauri Jetsu, a researcher, has proposed a new approach. Jetsu’s analysis, using a method called the Discrete Chi-square Method (DCM), suggests that planetary movements, especially those of Earth, Jupiter, and Mercury, play a key role in driving the sunspot cycle. His theory focuses on Flux Transfer Events (FTEs), where the magnetic fields of these planets interact with the Sun’s magnetic field. These interactions could create the sunspots and explain other solar phenomena like the Sun’s magnetic polarity reversing every 11 years. The Sun, our closest star, has been a subject of scient...
Post a Comment
Read more